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ABSTRACT
Aim: The aim of the present study was to produce chrysin–curcumin-loaded PCL-PEG nanofibres by an
electrospinning technique and to evaluate the biological activity of the chrysin–curcumin-loaded PCL-
PEG fibres for wound healing and its related genes using in vivo methods.
Materials and methods: The electrospinning method was carried out for the preparation of the
chrysin, curcumin and chrysin–curcumin-loaded PCL-PEG nanofibres with different concentrations. FTIR
and SEM were performed to characterize the chemical structures and morphology of the nanofibres. In
vitro drug release, as well as in vivo wound-healing studies were investigated in male rats. The expres-
sions of genes related to the wound-healing process were also evaluated by real-time PCR.
Results: Our study showed that the chrysin–curcumin-loaded nanofibres have anti-inflammatory prop-
erties in several stages of the wound-healing process by affecting the IL-6, MMP-2, TIMP-1, TIMP-2 and
iNOS gene expression. Our results demonstrated that the effect of the chrysin-loaded nanofibre, the
curcumin-loaded nanofibre and the chrysin–curcumin-loaded nanofibre in the wound-healing process
is dose dependent and in accordance with the obtained results in that it might affect the inflammation
phase more than the other stages of the wound-healing process.
Conclusion: We have introduced chrysin–curcumin-loaded PCL-PEG nanofibres as a novel compound
for shortening the duration of the wound-healing process.
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Chronic wound healing can result in infection and eventually
cancer. One of the aims of modern medicine is shortening
wound-healing time, increasing bioavailability and reducing
the side effects of drugs [1–3]. Among the many proposed
wound-healing protocols, physical methods such as infrared
waves [4], high-voltage electric waves [5], and drug delivery
involving biomolecules such as endostatin [6], vitamin A [7],
ascorbic acid [8] and growth factors [9] can be considered. A
myriad of studies has also introduced natural compounds
and “therapeutic agents” for decreasing wound “or ulcer”
healing time [10–13] for decreasing wound-healing time.
However, none of these approaches has been widely
accepted to be effective enough since wound healing is a
very complicated biological process that involves intracellular
and extracellular pathways [14]. Different types of immune
cells, endothelial cells, keratinocytes and fibroblasts play a
pivotal role in wound healing. Moreover, the proliferation,
differentiation and cellular migration of the aforementioned
cells can play a vital role in the wound healing pro-
cess [15–17].
Using a high dose of antibiotics also appears to not have
a strong effect on the wound-healing process since some-
times a low level of bacteria may aid in the wound-healing
process through the recruitment of immune cells [18]. Thus,
a balance of the normal flora should be maintained in the
wound area [19]. In this regard, several studies showed that
natural compounds such as herbal and mushroom extracts
possess biomedical potential [20–24]. It has been
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demonstrated that honey can remove harmful bacteria such
as E.coli, salmonella and Staphylococcus aureus [25,26] and
also plays a role in maintaining wound moisture which is
necessary for healing [27,28]. It has also been declared that
honey can promote angiogenesis in the wound area and epi-
thelial tissue regeneration [27].
Chrysin (5, 7-dihydroxyflavone) is a natural and biologically
active flavonoid in many extracts, such as plants gum, honey,
and propolis. Previous studies have reported that Chrysin
possesses potent anti-inflammatory and anti-oxidant proper-
ties [29,30]. On the other hand, curcumin is a naturally occur-
ring polyphenolic compound with a broad range of
favourable biological functions, including anti-cancer, anti-
oxidant and anti-inflammatory activities [31]. The low bio-
availability and in vivo stability of curcumin, however, require
the development of suitable carrier vehicles to deliver the
molecule in a sustained manner at therapeutic levels.
Despite the aforementioned functions, the poor water
solubility of chrysin and curcumin hinders its application as a
proper drug for wound healing [32–34]. This limitation calls
for the creation of an appropriate conveyor to increase the in
vivo stability of the bioactive compound, bioavailability and
eliminate their poor water solubility.
The wound-healing process involves a series of genes
such as IL-6 [35,36], tissue inhibitor of metalloproteinase
(TIMPs) [37,38], inducible nitric oxide synthase (iNOS) [39,40]
and matrix metalloproteinases (MMPs) [41,42]. There are sev-
eral studies that suggest the role of IL-6 in the early phase of
wound healing [35,43]. MMPs are involved in extracellular
matrix (ECM) degradation which makes for a poor wound
healing process. On the other hand, TIMPs are essential for
wound healing in smooth muscle cells, keratinocytes, fibro-
blasts and also endothelial cells by targeting MMPs [44].
Furthermore, iNOS plays a significant role in wound healing
when free radical levels are elevated [45]. In recent years, the
effect of reactive oxygen species (ROS) is under focus in dif-
ferent tissues because of its great influence on healing path-
ways [46–49].
The aim of the present study is to fabricate chrysin–curcu-
min-loaded PCL-PEG nanofibres using the electrospinning
technique [50,51] and then evaluate the biological activity of
the chrysin–curcumin-loaded PCL-PEG fibres on the wound




Polyethylene glycol (PEG) with a molecular weight (Mw) of
4000, dichloromethane, e-caprolactone (e-CL), dimethyl sulf-
oxide (DMSO), diethyl ether and methanol were purchased
from Merck (Darmstadt, Germany). Tween20, chrysin and cur-
cumin were provided by Sigma-Aldrich (St Louis, MO, USA)
and Stannous octoate (Sn(Oct)2) was supplied by Alfa Aesar.
Healthy male rats (2 and 3weeks of age) were purchased
from Pasteur Institute of Iran. TRIzol reagent, the QuantiTect
reverse transcription kit, and the QuantiTect SYBR Green real-
time PCR (RT-PCR) kit were purchased from Roche
(Mannheim, Germany). A cDNA synthesis kit and a Gene JET
RNA purification kit were purchased from Thermo Fisher
Scientific (Waltham, USA).
Synthesis of PCL/PEG/PCL triblock copolymer
The most methods that follow goes on, described before in
our previous study [1]. As we showed in our previous study,
PCL/PEG/PCL copolymers were prepared by the ring-opening
polymerization (ROP) of e-CL in the presence of PEG, using
stannous octoate as a catalyst. In summary, 1 g of polyethyl-
ene glycol (PEG4000), 10ml of e-CL, and Sn(Oct)2 (0.5wt.% of
monomers) were added to a 25-ml round-bottom flask sup-
ported by a nitrogen atmosphere [1]. The solution was
heated to 130 C for 6 h while stirring. dichloromethane was
used for dissolving the resulting polymer and precipitated in
cold diethyl ether three times and after that dried at room
temperature for 72 h.
Preparation of chrysin- and curcumin-loaded nanofibre
with utilization of electrospinning method
Like as this method shown before [1], PCL/PEG/PCL (10%
w/v) was dissolved in acetone, chloroform, methanol (at a 2:
1.5: 1.5 ratio) and DMSO (minimal amount for dissolving
chrysin) to prepare the PCL/PEG/PCL solution. For the prepar-
ation of chrysin-loaded nanofibers, 5, 10 and 15% (w/w)
chrysin (relative to the ratio of PCL-PEG-PCL) were added to
the solvent. In the next step, 5, 10 and 15% (w/w) curcumin
(relative to the ratio of PCL-PEG-PCL) were added to the solv-
ent. To prepare the chrysin–curcumin-loaded nanofibre, three
different conditions were followed as the addition of: (1) 5%
(w/w) chrysin and 10% (w/w) curcumin; (2) 10% (w/w) chrysin
and 5% (w/w) curcumin; (3) 7.5% (w/w) chrysin and 7.5%
(w/w) curcumin (relative to PCL-PEG-PCL w/w) to the solvent.
Finally, a PCL-PEG-PCL triblock copolymer with a ratio of
10% (w/v) was added to the above-described solutions and
stirred for 24 h at room temperature. A 5-ml plastic syringe
with a blunt-ended metal needle tip (gauge 16) was used for
each solution. The spinning solution was delivered at a con-
trolled feeding rate of 2ml/h, and the voltage between the
ground collector on the electrospinning device and the needle
tip (Fanavaran Nano-Meghyas, Tehran, Iran) was adjusted to a
range of 28–30 kV. The distance between the nozzle and the
collector and the rotating speed of the drum were fixed at
10 cm and 200 rpm, respectively. The metal collector was cov-
ered with an aluminium foil. All electrospinning experiments
were carried out at room temperature [52,53]. To remove the
excess DMSO after electrospinning, all nanofibres were
washed with deionized water and dried in vacuum at 40 C.
Scanning electron microscopy
By using scanning electron microscopy (SEM; model 6400;
JEOL, Boston, MA, USA) the morphology and diameter of the
PCL-PEG nanofibres with different concentrations of chrysin
and curcumin-loaded PCL-PEG nanofibres were determined.
At an accelerating voltage of 26 kV, samples were imaged.
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Fourier transform infrared spectroscopy (FTIR)
The chemical structure of the PCL-PEG nanofibres, as well as
the chrysin- and curcumin-loaded PCL-PEG nanofibres were
performed by FTIR. The FTIR spectra of the nanofibres were
obtained by using a Shimadzu 8400 s infrared spectropho-
tometer (Kyoto, Japan).
In vitro chrysin and curcumin release assay
To investigate the release kinetics of chrysin and curcumin
from the nanofibres mats, a piece of fibre mat (20–30mg,
25250.1mm3) was placed into a 20ml vial of phosphate-
buffered saline (PBS, pH 7.4) containing Tween 20 (0.5%) and
DMSO (5%) following by incubation at 37 C with a shaking
rate of 150 rpm for 15 days. In specific intervals, 1ml of the
media solution was taken to evaluate the absorbance of the
chrysin and curcumin nanofibres by a UV spectrophotometer
at a wavelength of 425 nm, and then, 1ml fresh buffer was
replaced in the solution. The buffer solution was used for the
medium to determine the calibration curve. The release per-
centages of the chrysin and curcumin nanofibres were calcu-
lated according to the following equation:
Release %ð Þ ¼ Released Chrysin or Curcumin
Total Loaded Chrysin or Curcumin
 100
In vivo wound-healing studies
In the Faculty of Advanced Sciences at Tabriz University of
Medical Sciences this experiment was conducted. We pur-
chased ninety male rats (weight: 250–300 grams) from the
Tabriz University of Medical Sciences central animal house,
and they caged in pathogen-free and in addition to food and
water ad libitum, facilities on a 12-h12-h lightdark cycle.
University of Tabriz animal ethics committee have approved
all experiments. The rats were allocated to 10 groups and
each group included nine rats. The most steps of wound cre-
ation and the other manners method is similar to our previ-
ous study [1]. After anaesthesia, we created an open
excision-type wound (2 2 cm2) on the thoracic-lumbar
region of the rats to the depth of the panniculus carnosus
region of rats. The wound was not dressed or covered. After
recovery of the animals from anaesthesia, appropriate disin-
fected individual cages were prepared for caging them. All
nanofibres were UV sterilized before use and each of them
was placed on the wound site and slightly around the
wound. We considered 10 groups; The first group was control
group which received the PCL-PEG nanofibres for treatment
while the 2nd, 3th and 4th groups were treated with 5%
(w/w), 10% (w/w) and 15% (w/w) chrysin-loaded nanofibres
and the 5th, 6th and 7th groups received 5% (w/w), 10%
(w/w) and 15% (w/w) curcumin-loaded nanofibres, respect-
ively. The 8th, 9th and 10th groups were treated with the
chrysin 5%-curcumin 10% (w/w), chrysin 10%-curcumin 5%
(w/w) and chrysin 7.5%-curcumin 7.5% (w/w) loaded nanofi-
bres, respectively. Differences in the wound area were meas-
ured at 5, 10 and 15 days after treatment with nanofibres.
The extent of wound healing was reported as the percentage
of wound area that remained exposed. Each group, as well
as the control, were tested on three rats and the mean value
was recorded.
Wound size %ð Þ ¼ W5: 10 and 15
W0
 100
where W5, W10 and W15 are the wound areas after 5, 10 and
15 days treatment, and W0 is the initial wound area. Also
wound sampling was done at 5, 10 and 15 days after treat-
ment. At the end of each treatment time point, full-thickness
sections of the wound were dissected and stored in 70 C
until RNA extraction.
RNA extraction and cDNA synthetic
As described before [1], the sections which included full
thickness of the wound were stored in 70 C until RNA
extraction. For RNA recovery from tissue biopsies by disrup-
tion, 500ml TRIzol solution (Invitrogen, Carlsbad, CA, USA)
was used, and then, for homogenization, we used a pestle
mixer (Scientific Specialties, Randallstown, MD, USA), and
then, RNA was extracted in 50ml chloroform that prepared
form Sigma-Aldrich. After that, isopropanol (Sigma, Castle
Hill, NSW, Australia) used for precipitating RNA from the
aqueous phase, and ice-cold 75% (w/w) ethanol used for
washing the pellet. Then, in 100 ll Milli-Q water the pellet
was dried and resuspended. 1 ll of Oligo (dT) primers, 1 lg
of total RNA and 11 ll of diethylpyrocarbonate (DEPC) treated
water were mixed in dry ice followed by incubation at 65 C
for 5min and then stored on dry ice for 1min to synthesize
the complementary DNA (cDNA). 4 ll of 5X reaction buffer,
1 ll of RiboLockTM RNase Inhibitor (20U/ll) and 2 ll of
(10mM) dNTP Mix, mixed as the reaction mixture of the com-
ponents, was added before incubation at 25 C for 5min. 2 ll
of M-MuL V reverse transcriptase (20U/ll) was used for RNA
reverse-transcription and then incubated at 25 C for 5min
and further incubated at 42 C for 60min. The reaction was
terminated at 70 C for 5min.
Real-time quantitative PCR
Based on the same previous method [1], for all tissue sam-
ples, reverse transcription was performed in a single batch
and in the same PCR run were analysed for a given primer
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set. Each reaction volume (20ml total) in the PCR contained
3ll of cDNA and a SYBR Green PCR Master Mix that pur-
chased from Applied Biosystems was used as the amplifica-
tion reagent supplement. The program for real-time PCR
included the following: initial denaturation at 95 C for 10 s,
followed by cycles of denaturation at 94 C for 15 s, annealing
at 58 C for 30 s, and 72 C for 30 s. After that, the melting
curve analysis of 70 C to 95 C used for assessing the ampli-
cons. Table 1 reports the primers sequences for the RT-PCR.
The 2DDCT method was used to calculate DCT values in rela-
tion to b-actin CT values, in which DCT used for representing
the difference between the CT value of the target genes and
the CT value of b-actin.
Results
Morphology of the nanofibrous scaffolds
To investigate the physicochemical characterization of the
nanofibres, the scaffolds were characterized by SEM. The
average diameter of the PCL-PEG nanofibres and chrysin-
loaded PCL-PEG nanofibres, curcumin-loaded PCL-PEG nanofi-
bres and the chrysin–curcumin-loaded PCL-PEG nanofibres
were in the range of 50–300 nm. Figure 1(A) shows the drug-
free nanofibre of PCL-PEG with a nearly smooth surface and
net-like structure. Likewise, the chrysin- and curcumin-loaded
PCL-PEG nanofibre at 5% (w/w) showed a net-like structure
with beads (Figures 1(B,E)). Increasing the chrysin concentra-
tion to 10% (w/w) significantly changed the size of beads
and granular beads (Figure 1(C)). According to Figure 1(D),
although the chrysin-loaded PCL-PEG nanofibres 15% (w/w)
were almost the same as the 10% (w/w), the granular beads
were more populated. As shown in Figure 1(F), the diameter
of the nanofibres increased in the curcumin-loaded PCL-PEG
nanofibre 10% (w/w) and according to Figure 1(G) the diam-
eter increased even more for the curcumin-loaded PCL-PEG
nanofibre 15% (w/w). Figure 1(H) reveals that the diameter of
nanofibres increased for the 5% chrysin 10% curcumin (w/w).
According to the Figure 1(I,J) which is related to 7.5%
chrysin–7.5% curcumin (w/w) and 10% chrysin-5% curcumin
(w/w), the beads transformed to the granular surface and
their diameter increased. Due to the precipitation of curcu-
min at higher concentrations, the maximum concentration of
curcumin that could be loaded in the PCL-PEG nanofibres
was 15% (w/w).
FTIR results
Figure 2(a) shows the FT-IR spectra of the PCL-PEG-PCL tri-
block copolymers. The peak at 1107 cm1 is attributed to the
C–O–C stretching vibration of the repeated -OCH2CH2 units
present in PEG. Stretching vibrations of the ester carbonyl
group appeared at 1726 cm1. The peak at 1630 cm1 is
attributed to the C–C stretching. Characteristic bonds
appeared at 3442 cm1 (O–H, stretching) for the phenolic
hydroxyl group. Signals at 2945 and 2866 cm1 correspond
to the characteristic absorption of the C–H stretching bonds
of –CH2CH2, which are similar to those of e-CL. These signals
demonstrate the formation of the PCL-PEG-PCL
triblock copolymer. Figure 2(b–d) are related to the curcumin
Figure 1. SEM micrographs showing the morphology of the PCL-PEG nanofibres: (A) free PCL-PEG; (B) Chrysin 5% loaded PCL-PEG nanofibre; (C) Chrysin 10%
loaded PCL-PEG nanofibre; (D) Chrysin 15% loaded PCL-PEG nanofibre; (E) Curcumin 5% loaded PCL-PEG nanofibre; (F) Curcumin 10% loaded PCL-PEG nanofibre;
(G) Curcumin 15% loaded PCL-PEG nanofibre; (H) Chrysin 5%-Curcumin 10% loaded PCL-PEG; (I) Chrysin 7.5%-Curcumin 7.5% loaded PCL-PEG and (J) Chrysin
10%-Curcumin 5% loaded PCL-PEG.
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PCL-PEG nanofibre, the chrysin PCL-PEG nanofibre and the
curcumin–chrysin PCL-PEG nanofibre, respectively.
In vitro release study
Figure 3 shows the release behaviour of the chrysin and cur-
cumin in PBS from the nanofibre mat (A: chrysin and B: cur-
cumin). The maximum amount of chrysin and curcumin were
released from the nanofibres for day 1 (Figure 3(A,B)). As
shown, the maximum release of chrysin and curcumin from
the nanofibres is related to the amount of chrysin and curcu-
min. For example, the maximum release of chrysin from the
nanofibre mat with 5, 10 and 15% chrysin was about 59, 68
and 81.5%, respectively. Based on the Figure 3(A), the in vitro
release of chrysin from the nanofibre mat was greater and
faster than the curcumin.
In vivo wound closure study
Figure 4 shows the picture of one of the rats treated with
curcumin nanofibres (using chrysin 7.5%–curcumin 7.5%
nanofibre, 5 days after treatment). The wound closure per-
centage in all rats was measured on 5, 10, and 15 days
post-injury and the effect of chrysin, curcumin and
chrysin–curcumin-loaded nanofibres on wound closure is
shown in Figure 5(A–C), respectively. According to these
graphs, in all groups, the percentage of wound closure was
Figure 2. FTIR spectrum of: (a) PCL-PEG-PCL triblock copolymers, (b) Curcumin
PCL-PEG nanofiber, (c) Chrysin PCL-PEG nanofiber, and (d) Chrysin–Curcumin
PCL-PEG nanofiber.
Figure 3. Release behaviour of chrysin and curcumin loaded nanofibres in PBS: (A) Chrysin loaded PCL-PEG nanofibre and (B) Curcumin loaded PCL-PEG nanofibre.
(a) Chrysin 5%, (b) Chrysin 10%, (c) Chrysin 15%, (d) Curcumin 5%, (e) Curcumin 10%, and (f) Curcumin 15%.
Figure 4. Manipulation of Chrysin 7.5%-Curcumin 7.5% loaded nanofibre on
the wound.
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higher than controls. In higher doses, the chrysin-loaded
nanofibre significantly promoted the wound-healing process,
in a way that the percentage of wound closure on day 15
was 78, 82 and 88%, for 5, 10 and the 15% chrysin-loaded
nanofibres, respectively (Figure 5(A)). On day 15, the percent-
age of wound closure for 5, 10, and 15% curcumin nanofibre
was around 85, 87, and 92%, respectively (Figure 4(B)). In
general, although the wound closure efficacy of the nanofi-
bres containing curcumin was higher than that of chrysin,
there was no significant difference between the different per-
centage of curcumin compared to chrysin. Figure 5 also dem-
onstrates that there is no synergistic effect between chrysin
and curcumin for wound closure.
The effect of chrysin and curcumin nanofibres on
IL-6 expression
On day 5, the results revealed that the chrysin-loaded
PCL-PEG nanofibre 15% (w/w) significantly elevated the
expression of IL-6 compared to 5, 10% (w/w) and the curcu-
min-loaded PCL-PEG 10% (w/w) more significantly elevated
the expression of IL-6 than 5, 15% (w/w) in comparison with
the control group (p values <.05). Likewise, the chrysin–cur-
cumin-loaded PCL-PEG 7.5% (w/w) more significantly elevated
IL-6 expression than the other chrysin–curcumin-loaded PCL-
PEG nanofibres compared to the control group (p values
<.05) (Figure 6(A)).
On day 10, the chrysin-loaded PCL-PEG nanofibre 15%
(w/w) significantly elevated the expression of IL-6 than the 5,
10% (w/w) and the curcumin-loaded PCL-PEG 10% (w/w)
even more significantly elevated the expression of IL-6 than
the nanofibres 5, 15% (w/w) in comparison with the control
group (p values <.05). The chrysin–curcumin-loaded PCL-PEG
7.5% (w/w) and chrysin 5%-curcumin 10% were more effect-
ive for promoting the expression of IL-6 than the chrysin
10%-curcumin 5% in comparison with the control group
(p values <.05) (Figure 6(B)).
The effect of chrysin and curcumin nanofibres on
MMP-2 expression
On day 5, the chrysin loaded PCL-PEG 15% (w/w) more sig-
nificantly elevated the expression of MMP-2 than the
Figure 5. Wound closure percentage: (A) Chrysin, (B) Curcumin and (C)
Chrysin–Curcumin-loaded nanofibres. The X-axis represents the elapsed day and
the Y-axis shows the wound closure percentage.
Figure 6. The expression of IL-6 after (A) 5 days treatment (B) 10 days treat-
ment. X-axis represents the study groups and Y-axis shows fold change of the
genes. Statistical analysis was performed by ANOVA. Each point represents the
mean ± SEM. p values <.05 vs. control. p< .05.
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nanofibre 5, 10% (w/w) and compared to control group.
Additionally, the curcumin-loaded PCL-PEG 15% (w/w)
showed the same trend in comparison with nanofibers 5,
10% (w/w) (p values <.05). Compared to the control group,
the chrysin 5%-curcumin 10% and the chrysin–curcumin-
loaded PCL-PEG 7.5% (w/w) elevated the expression of MMP-
2 more than the chrysin 10%-curcumin5% loaded PCL-PEG
(w/w) (p values <.05) (Figure 7(A)). On day 10 post-treatment,
the chrysin-loaded PCL-PEG 10% (w/w) remarkably elevated
the expression of MMP-2 than the nanofibres 5, 15% (w/w)
and the control group; and the same trend was observed for
the curcumin-loaded PCL-PEG 10% (w/w) compared to the
nanofibres 5, 15% and the control group (w/w) (p values
<.05). The chrysin–curcumin-loaded PCL-PEG 7.5% (w/w)
were more effective in promoting the expression of MMP-2
than the chrysin 5%-curcumin 10% and chrysin 10%-
curcumin 5% (w/w) as well as the control group (p values
<.05) (Figure 7(B)).
The effect of chrysin and curcumin nanofibres on
TIMP-1 expression
On day 5, in comparison with the control group, the chrysin-
loaded PCL-PEG 15% (w/w) significantly elevated the expres-
sion of TIMP-1 compared to the nanofibres 5, 10% (w/w); and
the same trend was observed in the effect of curcumin-
loaded PCL-PEG 15% (w/w) on the expression of TIMP-1 than
the nanofibres 5, 10% (w/w) (p values <.05). Likewise, the
chrysin 5%-curcumin 10% remarkably elevated the expression
of TIMP-1 more than the chrysin 10%-curcumin 5% loaded
PCL-PEG and the chrysin–curcumin-loaded PCL-PEG 7.5%
(w/w) (p values <.05) (Figure 8(A)). On day 10, the chrysin-
loaded PCL-PEG 10% (w/w) promoted the expression of
TIMP-1 more than the nanofibres 5, 15% (w/w) and the
control group; and a similar trend was noticed for the curcu-
min-loaded PCL-PEG 15% (w/w) in the expression of TIMP-1
compared to the nanofibres 5, 10% (w/w) and the control
group, but these levels were not significantly different. In
comparison with control group, the chrysin 5%–curcumin
10% elevated the expression of TIMP-1 more than the chrysin
Figure 7. The expression of MMP-2 after (A) 5 days of treatment and (B) 10 days
of treatment. The X-axis represents the study groups and the Y-axis shows the
fold change of the genes. Statistical analysis was done by ANOVA. Each point
represents the mean ± SEM. p values< .05 vs. control. p< .05.
Figure 8. The expression of TIMP-1 after (A) 5 days of treatment and (B) 10 days
of treatment. X-axis represents the study groups and Y-axis shows the fold
change of the genes. Statistical analysis was done by ANOVA. Each point repre-
sents the mean ± SEM. p values< .05 vs. control. p< .05.
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10%-curcumin5% loaded PCL-PEG and the chrysin–curcumin-
loaded PCL-PEG 7.5% (w/w), but these levels were not signifi-
cant (Figure 8(B)).
The effect of chrysin and curcumin nanofibres on
TIMP-2 expression
On day 5, in comparison with the control group, the chrysin-
loaded PCL-PEG 15% (w/w) significantly elevated the expres-
sion of TIMP-2 more than the nanofibres 5, 10% (w/w) and
the curcumin-loaded PCL-PEG 15% (w/w) more significantly
elevated the expression of TIMP-2 than the nanofibres 5, 10%
(w/w) (p values <.05). Furthermore, in comparison with con-
trol group, the chrysin 5%–curcumin 10% elevated the
expression of TIMP-2 more than the chrysin 10%–curcumin
5% loaded PCL-PEG and the chrysin–curcumin-loaded PCL-
PEG 7.5% (w/w) (p values <.05) (Figure 9(A)). On day 10,
in comparison with the control group, the chrysin-loaded
PCL-PEG 15% (w/w) significantly elevated the expression of
TIMP-2 more than the nanofibres 5, 10% (w/w); and the cur-
cumin-loaded PCL-PEG 15% (w/w) more significantly elevated
the expression of TIMP-2 than the nanofibres 5, 10% (w/w)
(p values <.05). Likewise, the same trend was observed for
the chrysin 10%–curcumin 5% in terms of promoting the
expression of TIMP-2 compared to the chrysin 5%–curcumin
10% loaded PCL-PEG and the chrysin–curcumin-loaded PCL-
PEG 7.5% (w/w) (p values <.05) (Figure 9(B)).
The effect of chrysin and curcumin nanofibres on
iNOS expression
On day 5, in comparison with the control group, the chrysin-
loaded PCL-PEG 15% (w/w) reduced more the expression of
iNOS than the nanofibres 5, 10% (w/w) and the curcumin-
loaded PCL-PEG 15% (w/w) more significantly reduced
the expression of iNOS than the nanofibres 5, 10% (w/w)
(p values <.05). The chrysin 5%–curcumin 10% reduced the
expression of iNOS more than the chrysin 10%-curcumin 5%
loaded PCL-PEG and the chrysin–curcumin-loaded PCL-PEG
7.5% (w/w) as well as the control group (p values <.05)
(Figure 10(A)). On day 10, the chrysin-loaded PCL-PEG 15%
(w/w) more significantly reduced the expression of iNOS com-
pared to the nanofibers 5, 10% (w/w) and the curcumin-
loaded PCL-PEG 5% (w/w) even more reduced the expression
of iNOS in comparison with the nanofibres 10, 15% (w/w)
(p values <.05). The chrysin–curcumin-loaded PCL-PEG 7.5%
reduced the expression of iNOS more than the chrysin
10%–curcumin 5% loaded PCL-PEG and chrysin 5%-curcumin
10% (w/w) in comparison with the control group (p values
<.05) (Figure 10(B)).
Discussion
The purpose of using the nanofibres in this study was to
solve the problem associated with the insolubility of chrysin
and curcumin-based on a simple principle that increasing the
surface area of the drug and carrier can enhance the dissol-
ution rate of the drug and provide a helpful pathway
for the delivery of water-insoluble drugs. Therefore, the
chrysin–curcumin-loaded nanofibre can be a more effective
and promising candidate in wound healing applications [54].
This interesting phenomenon for the chrysin-curcumin-
loaded nanofibre has not been reported elsewhere. In this
study, chrysin and curcumin presented a positive effect on
an open wound-healing model in rats and also its effect on
the expression of the different type of genes that are related
to wound healing such as IL-6, TIMPs, iNOS and MMPs were
systematically investigated.
IL-6 plays a critical role in inflammation and is produced
by inflammatory cells [43,55]. Based on previous studies, IL-6
has a regulatory role in leukocyte recruitment in inflamma-
tory conditions [56,57]. Also, it has been shown that IL-6
deficient mice have a low level of macrophages and neutro-
phils [36]. As the results show, chrysin and curcumin nanofi-
bres elevated IL-6 gene expression during the wound-healing
process after 10 days, and on day 10, the maximum
Figure 9. The expression of TIMP-2 after (A) 5 days of treatment and (B) 10 days
of treatment. The X-axis represents the study groups and the Y-axis shows the
fold change of the genes. Statistical analysis was done by ANOVA. Each point
represents the mean ± SEM. p values< .05 vs. control. p< .05.
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expression was elevated by chrysin 7.5%–curcumin 7.5%
loaded PCL-PEG. Based on these results, high doses of curcu-
min play a crucial role in inducing IL-6 expression.
Previous studies have been shown that MMP-2 gene is
expressed at wound sites during the healing process and
also MMPs have a crucial role in keratinocyte detachment
from the basement membrane and the other healing process
[58–62]. Based on these results, MMP-2 gene expression was
variable between groups for day 5 and day 10, so that in
chrysin and curcumin groups, the 15% concentration ele-
vated more MMP-2 expression and chrysin 10%–curcumin 5%
loaded PCL-PEG reduced MMP-2 expression. For day 10,
MMP-2 gene expression reduced in comparison with day 5
and also the curcumin group, especially curcumin 5% more
greatly reduced MMP-2 expression.
TIMP genes are related to the cell proliferation stage in
the process of wound healing [23], and any disturbance in
the expression of these genes may lead to a delayed wound
healing [36]. As our results showed, the expression of TIMP-1
reduced from day 1 to day 10. Also, it has been shown that
for day 5, a higher level of TIMP-1 expression was related to
the chrysin 5%-curcumin 10% loaded PCL-PEG, and for day
10, it was related to the chrysin 10% loaded PCL-PEG. On day
5, TIMP-2 expression higher level was related to chrysin
5%–curcumin 10% loaded PCL-PEG and for day 10, it was
related to the chrysin 10%–curcumin 5% loaded PCL-PEG, but
generally, TIMP-2 gene expression levels for day 10 were
lower than day 5.
Wound-healing processes have an interconnected relation-
ship with many components and one of these components is
iNOS which plays a key role in wound healing and closure
[63]. As the present results showed, the down-regulation of
iNOS gene for day 5 was related to the chrysin 5%-curcumin
10% loaded PCL-PEG and for day 10, the chrysin group in
comparison with curcumin group more greatly reduced iNOS
gene expression especially chrysin 15%. On the other hand,
chrysin 7.5%–curcumin 7.5% loaded PCL-PEG reduced more
iNOS gene expression than all of the other groups.
Conclusion
In conclusion, we have introduced here chrysin–curcumin-
loaded PCL-PEG nanofibres as a novel compound to shorten
the duration of the wound-healing process. The electrospin-
ning of a PCL-PEG-chrysin–curcumin solution was performed
and ended by the production of a yellow colour electrospun
mat without any significant accumulation of chrysin on the
surface. Our results showed that the chrysin–curcumin-loaded
nanofibres have anti-inflammatory properties in several
stages of the wound-healing process by affecting the IL-6,
MMP-2, TIMP-1, TIMP-2 and iNOS gene expression. These
results demonstrated that the effect of the chrysin-loaded
nanofibre, the curcumin-loaded nanofibre and the
chrysin–curcumin-loaded nanofibre in the wound-healing
process is somewhat dose dependent and in accordance
with the obtained results, it might affect the inflammation
phase more than the other stages of wound-healing process.
In this study, we focused on gene expression related to the
inflammation phase and the evaluation of the expression of
genes related to other phases, the proliferation and wound
closure properties need to be investigated further.
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Figure 10. The expression of iNOS after (A) 5 days of treatment and (B) 10 days
of treatment. The X-axis represents the study groups and Y-axis shows the fold
change of the genes. Statistical analysis was done by ANOVA. Each point repre-
sents the mean ± SEM. p values <.05 vs. control. p< .05.
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